for ensuring correct administration to patients for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. G16H20/10- ICT specially adapted for therapies or health-improving plans, e.g.for handling prescriptions, for steering therapy or for monitoring patient compliance G16H20/00- ICT specially adapted for therapies or health-improving plans, e.g.INFORMATION AND COMMUNICATION TECHNOLOGY SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA G16- INFORMATION AND COMMUNICATION TECHNOLOGY SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS.231100000041 toxicology testing Toxicity 0.000 description 1.238000009781 safety test method Methods 0.000 description 1.230000018109 developmental process Effects 0.000 description 1.239000003795 chemical substances by application Substances 0.000 description 1.206010069171 Product quality issue Diseases 0.000 description 1.238000010561 standard procedure Methods 0.000 description 2.206010067482 No adverse event Diseases 0.000 description 2.238000010200 validation analysis Methods 0.000 description 3.
238000009114 investigational therapy Methods 0.000 description 3.238000004891 communication Methods 0.000 claims abstract description 18.Assignors: EGAN, LARRY, CISZKOWSKI, MIETEK, NATARAJAN, SAYEE, PICKETT, LARRY, STAHL, JAKE Publication of US20080104613A1 publication Critical patent/US20080104613A1/en Application granted granted Critical Publication of US8666764B2 publication Critical patent/US8666764B2/en Status Active legal-status Critical Current Adjusted expiration legal-status Critical Links
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Priority to US86324306P priority Critical Priority to US86792306P priority Application filed by Purdue Pharma LP filed Critical Purdue Pharma LP Priority to US11/925,403 priority patent/US8666764B2/en Assigned to PURDUE PHARMA L.P. Original Assignee Purdue Pharma LP Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.) ( en Inventor Mietek Ciszkowski Larry Egan Sayee Natarajan Larry Pickett Jake Stahl Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.) Granted Application number US11/925,403 Other versions US8666764B2
Time limit for callnote free pdf#
Google Patents Adverse event data capture software, systems and methodologiesĭownload PDF Info Publication number US20080104613A1 US20080104613A1 US11/925,403 US92540307A US2008104613A1 US 20080104613 A1 US20080104613 A1 US 20080104613A1 US 92540307 A US92540307 A US 92540307A US 2008104613 A1 US2008104613 A1 US 2008104613A1 Authority US United States Prior art keywords adverse event event information machine representative information Prior art date Legal status (The legal status is an assumption and is not a legal conclusion. Google Patents US20080104613A1 - Adverse event data capture software, systems and methodologies US20080104613A1 - Adverse event data capture software, systems and methodologies
0 kommentar(er)
